Literature DB >> 1714516

Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16.

S A Comerford1, D J McCance, G Dougan, J P Tite.   

Abstract

There is strong evidence implicating human papillomavirus type 16 (HPV16) in the genesis of human genital cancer. Viral DNA has been identified in invasive carcinoma of the uterine cervix and in cell lines derived from cervical carcinomas. These sequences are actively transcribed, and translation products corresponding to the early (E)-region genes have been identified. The most abundant viral protein is the E7 protein, which has been shown to possess transforming activity for both established and primary cells. In addition, it has been shown to bind to a cellular tumor suppressor, the retinoblastoma gene product (pRb-105). In view of these properties, we have undertaken the immunological analysis of this protein and have identified four T-cell epitopes and three B-cell epitopes by using a series of overlapping peptides spanning the entire HPV16 E7 sequence. Two of the B-cell epitopes were recognized by antisera from mice with three different murine (H-2) haplotypes (k, d, and s) immunized with two different E7 fusion proteins and from Fischer rats seeded with baby rat kidney cells transformed by HPV16 E7 and ras. A third B-cell epitope was recognized by antisera from CBA mice seeded with HPV16 E7-expressing L cells. Two regions of the protein contain common B- and T-cell epitopes, one of which appears to be particularly immunodominant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714516      PMCID: PMC248923     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Chemical synthesis of human papillomavirus type 16 E7 oncoprotein: autonomous protein domains for induction of cellular DNA synthesis and for trans activation.

Authors:  J A Rawls; R Pusztai; M Green
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 2.  Immunobiology of human papillomavirus infection.

Authors:  H Kirchner
Journal:  Prog Med Virol       Date:  1986

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

4.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  DNA hybridisation of cervical smears.

Authors:  D J McCance; A Singer; M J Campion
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

6.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

7.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

Authors:  L P Chen; E K Thomas; S L Hu; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

8.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

9.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

Authors:  H J Huang; J K Yee; J Y Shew; P L Chen; R Bookstein; T Friedmann; E Y Lee; W H Lee
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

10.  Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men.

Authors:  I H Frazer; G Medley; R M Crapper; T C Brown; I R Mackay
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

View more
  13 in total

1.  Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology.

Authors:  D P Harris; H M Vordermeier; A Arya; K Bogdan; C Moreno; J Ivanyi
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

2.  Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity.

Authors:  W Shi; P Bu; J Liu; A Polack; S Fisher; L Qiao
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.

Authors:  M Nakagawa; D P Stites; S Farhat; A Judd; A B Moscicki; A J Canchola; J F Hilton; J M Palefsky
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

4.  Predominant recognition of species-specific determinants of the GroES homologues from Mycobacterium leprae and M. tuberculosis.

Authors:  B Chua-Intra; J Ivanyi; A Hills; J Thole; C Moreno; H M Vordermeier
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

5.  Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.

Authors:  J C Steele; T Stankovic; P H Gallimore
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Authors:  Jinsong Zhang; S Munir Alam; Hilary Bouton-Verville; Yao Chen; Amanda Newman; Shelley Stewart; Frederick H Jaeger; David C Montefiori; S Moses Dennison; Barton F Haynes; Laurent Verkoczy
Journal:  J Immunol       Date:  2014-01-24       Impact factor: 5.422

Review 7.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

8.  Minute time scale prolyl isomerization governs antibody recognition of an intrinsically disordered immunodominant epitope.

Authors:  Marisol Fassolari; Lucia B Chemes; Mariana Gallo; Clara Smal; Ignacio E Sánchez; Gonzalo de Prat-Gay
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

9.  Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma.

Authors:  M F Baay; J M Duk; M P Burger; J Walboomers; J ter Schegget; K H Groenier; H W de Bruijn; E Stolz; P Herbrink
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

10.  Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers.

Authors:  Khadem Ghaebi Nayereh; Ghaeb Khadem
Journal:  Iran J Basic Med Sci       Date:  2012-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.